Oral drug combo tested for Tough-to-Treat leukemia relapse
NCT ID NCT05799079
Summary
This study tested whether a combination of three oral medications could help control acute myeloid leukemia (AML) in adults whose cancer returned after a donor stem cell transplant. The goal was to see if the treatment could put the leukemia back into remission and how long patients might live. The trial was terminated after enrolling only one participant, so no conclusions can be drawn from it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.